Paclitaxel and Bavituximab in Treating Patients With HER2-Negative Metastatic Breast Cancer

Clinical trial NCT01288261 · COMPLETED

Trial details

NCT number: NCT01288261
Sponsor: University of Arizona
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Human Epidermal Growth Factor 2 Negative Carcinoma of Breast Male Breast Cancer Recurrent Breast Cancer Stage IIIC Breast Cancer Stage IV Breast Cancer

Start date: 2011-01-01
Primary completion: 2013-05-01
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.